The cancer cells escaped cell death only when the team exposed them to chemotherapy drugs like raltitrexed, a treatment for advanced bowel cancer that works by inhibiting DNA replication. When they ...

A new study from Cedars-Sinai Cancer reveals a potential way to overcome tumor resistance to a common chemotherapy drug ...

The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...

chemotherapy is designed to disrupt the cell cycle. By targeting specific stages of the cycle, chemotherapy drugs aim to stop cancer cells from growing and dividing. Cancer cells grow through a ...

Prostate cancer remains a global health challenge, ranking as the second most commonly diagnosed cancer among men. Although ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Even newer features are being developed such as using targeted drugs as the payload instead of chemotherapy, such as small ...

Researchers have discovered how chemotherapy can change tumors, making them more vulnerable to new types of treatments. These ...

Prostate cancer, especially in advanced stages such as castration-resistant prostate cancer, is challenging to treat. Traditional therapies targeting androgen receptor (AR) signaling have limited ...

Study: Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy ... analysis. Cell states clustered into two groups. One group comprised cell cycle-related ...